DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Visipaque (Iodixanol Intravascular) - Summary

 
 



VISIPAQUE SUMMARY

VISIPAQUE™
(iodixanol) Injection
     320

VISIPAQUE™ (iodixanol) Injection, 5,5'-[(2-hydroxy-1,3-propanediyl)bis (acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodo-1,3- benzenedicarboxamide], is a dimeric, isosmolar, nonionic, water-soluble, radiographic contrast medium with a molecular weight of 1550.

INTRA-ARTERIAL

VISIPAQUE Injection (270 mgI/mL) is indicated for intra-arterial digital subtraction angiography.

VISIPAQUE Injection (320 mgI/mL) is indicated for angiocardiography (left ventriculography and selective coronary arteriography), peripheral arteriography, visceral arteriography, and cerebral arteriography.

INTRAVENOUS [For information on the concentrations and doses for the pediatric population see the Precautions–Pediatric Use, Clinical Pharmacology–Special Populations, and Dosage and Administration sections.]

VISIPAQUE Injection (270 mgI/mL) is indicated for CECT imaging of the head and body, excretory urography, and peripheral venography.

VISIPAQUE Injection (320 mgI/mL) is indicated for CECT imaging of the head and body, and excretory urography.


See all Visipaque indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Visipaque (Iodine Intravascular)

FDA Panel Divided Over Diagnostic HbA1c Test
Source: MedPageToday.com - medical news plus CME for physicians [2016.07.22]
(MedPage Today) -- Called generally safe and accurate, but panel questions future of use

Medical News Today: 'Smart thread' enables 3-D tissue embedding for medical diagnostics
Source: Featured Health News from Medical News Today [2016.07.21]
Researchers have embedded thread-based microfluidic networks with sensors inside 3-D tissue to measure tissue properties and transmit them wirelessly.

'Smart thread' enables 3-D tissue embedding for medical diagnostics
Source: Medical Devices / Diagnostics News From Medical News Today [2016.07.21]
Researchers have embedded thread-based microfluidic networks with sensors inside 3-D tissue to measure tissue properties and transmit them wirelessly.

Zika virus: Antibodies identified with therapeutic and diagnostic potential
Source: Immune System / Vaccines News From Medical News Today [2016.07.18]
A team of researchers from the Institute for Research in Biomedicine (IRB, USI Università della Svizzera italiana) and the Swiss biotech company Humabs BioMed SA has identified novel therapeutic...

5th Semi-Annual Medical Device & Diagnostic Labeling Conference, September 29-30, 2016, Phoenix
Source: Conferences News From Medical News Today [2016.07.05]
As medical device and diagnostic manufacturers continue to develop life enhancing products for patients across the globe, medical product labels hold an increasingly important position in providing...

more news >>

Published Studies Related to Visipaque (Iodine Intravascular)

Alcohol-based chlorhexidine vs. povidone iodine in reducing skin colonization prior to regional anesthesia procedures. [2011.07]
CONCLUSION: For skin disinfection prior to the neuraxial blockade procedure, the use of alcohol-based chlorhexidine compared with the use of povidone iodine lowered the incidence of insertion-site-colonization.

MDCT angiography for detection of pulmonary emboli: comparison between equi-iodine doses of iomeprol 400 mgI/mL and iodixanol 320 mgI/mL. [2009.06]
OBJECTIVES: To compare iomeprol 400 and iodixanol 320 in pulmonary artery MDCTA in subjects with suspected pulmonary embolism... CONCLUSION: The greater iodine delivery rate achievable with iomeprol 400 compared to iodixanol-320 at equi-iodine dose and injection rate permits consistently greater attenuation at all levels of the pulmonary arterial tree.

Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. [2006.09.05]
OBJECTIVES: This study sought to compare the nephrotoxicity of iodixanol and ioxaglate in patients with renal impairment undergoing coronary angiography. BACKGROUND: Iodixanol, a nonionic, dimeric, iso-osmolar contrast medium (IOCM), may be less nephrotoxic than low-osmolar contrast media (LOCM) in high-risk patients... CONCLUSIONS: The IOCM iodixanol was significantly less nephrotoxic than ioxaglate, an ionic, dimeric LOCM. (The RECOVER Trial; http://clinicaltrials.gov; NCT00247325).

Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. [2005.08]
The institutional review board approved this study, and all patients gave written informed consent. One hundred twenty-five patients scheduled to undergo retrospectively electrocardiographically gated 16-detector row computed tomographic coronary angiography were prospectively randomized into the following five groups with respect to the intravenous administration of a 140-mL bolus of contrast material at 4 mL/sec: group 1 (iohexol [300 mg of iodine per milliliter]), group 2 (iodixanol [320 mg I/mL]), group 3 (iohexol [350 mg I/mL]), group 4 (iomeprol [350 mg I/mL]), and group 5 (iomeprol [400 mg I/mL])...

Coronary stent evaluation with coronary computed tomographic angiography: comparison between low-osmolar, high-iodine concentration iomeprol-400 and iso-osmolar, lower-iodine concentration iodixanol-320. [2014]
stents with MDCT-CA... CONCLUSIONS: Iodixanol-320 provides better image quality of coronary stents,

more studies >>

Reports of Suspected Visipaque (Iodine Intravascular) Side Effects

Pyrexia (10)Renal Failure Acute (10)Infusion Site Extravasation (7)Hyperkalaemia (6)Headache (6)Lactic Acidosis (6)Nausea (6)Diarrhoea (6)Abdominal Pain (5)Confusional State (5)more >>


Page last updated: 2016-07-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015